Multiple Sclerosis, Relapsing-Remitting Clinical Trials

242 clinical trials for Multiple Sclerosis, Relapsing-Remitting across international registries, including 19 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation — RECRUITING · NA
• PENTAGON: MS-Related Disability Worsening and Thalamic Volume Loss — RECRUITING
• Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy — RECRUITING · PHASE1
• Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis — RECRUITING · PHASE3
• Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis — RECRUITING · PHASE4
• Intermittent Hypoxia in Persons With Multiple Sclerosis — RECRUITING · NA
• Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS — RECRUITING · NA
• Fatigue Alleviation Through Neuromodulating Therapy in Multiple Sclerosis — RECRUITING · NA
• Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland) — RECRUITING
• Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis — RECRUITING · NA
• TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis — RECRUITING · PHASE2
• Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis — RECRUITING · NA
• Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone Administration — RECRUITING · PHASE2
• Multiple Sclerosis and the Effects of Ketogenic Diet Therapy — RECRUITING · NA
• Light Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple Sclerosis — RECRUITING · NA
• Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands — RECRUITING
• MS-ResearchBiomarkerS — RECRUITING
• Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS — RECRUITING · PHASE3
• Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis — RECRUITING
• Examining Effects of Tysabri on Cognitive Fatigue Using fMRI — COMPLETED
• Examining Effects of Ocrevus on Cognitive Fatigue Using fMRI — COMPLETED
• Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial — ACTIVE_NOT_RECRUITING · NA
• A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS — COMPLETED · PHASE3
• Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With Immunosuppressant — COMPLETED · NA
• Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis — COMPLETED · PHASE4
• Effects of Chiropractic Care on Cytokine Levels in Multiple Sclerosis — COMPLETED · NA
• Effects of Task-oriented Training on Functional Mobility and Fatigue in Patients With Multiple Sclerosis — COMPLETED · NA
• RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis — WITHDRAWN · PHASE1
• Peer Support Impact on Therapeutic Adherence in Patients With Multiple Sclerosis — ACTIVE_NOT_RECRUITING · NA
• B Cell Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing Remitting Multiple Sclerosis — ACTIVE_NOT_RECRUITING · PHASE4
• Cognition and MRI Markers in MS Patients With Aubagio® Treatment — COMPLETED · NA
• Safety and Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Multiple Sclerosis — COMPLETED · PHASE1
• ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients — ACTIVE_NOT_RECRUITING
• RC18 in Patients With Relapsing Remitting Multiple Sclerosis：a Phase II Trial — TERMINATED · PHASE2
• Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis — ACTIVE_NOT_RECRUITING · PHASE3
• The Synergistic Effects of AIH and FES in Persons With MS — ACTIVE_NOT_RECRUITING · NA
• Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health Care — NOT_YET_RECRUITING
• Evaluation of the Impact of Lesions of the Motor and Proprioceptive Brain and Pan-medullary Pathways on Their Clinically and Electrophysiologically Assessed Function in Multiple Sclerosis — COMPLETED · NA
• Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis — NOT_YET_RECRUITING · NA
• A Study to Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of Natalizumab (BG00002) Administered Subcutaneously to Japanese Participants With Relapsing-Remitting Multiple Sclerosis — TERMINATED · PHASE3
• A Study to Describe the Switching From a First- or Second-line Disease Modifying Therapy (DMT) to Ozanimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) — COMPLETED
• Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis — COMPLETED · PHASE2
• Efficacy of Diet on Quality of Life in Multiple Sclerosis — ACTIVE_NOT_RECRUITING · NA
• A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis — ACTIVE_NOT_RECRUITING · PHASE3
• A Study Investigating the Utilization, Effectiveness and Quality of Life in Clinical Practice in Germany for Participants With Relapsing-remitting Multiple Sclerosis Treated With Ozanimod (Zeposia®) — COMPLETED
• Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS — ACTIVE_NOT_RECRUITING · PHASE4
• Corticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple Sclerosis — COMPLETED · PHASE2
• A Post-Authorization, Long-term Study of Ozanimod Real-world Safety — ACTIVE_NOT_RECRUITING
• Measurement of Relaxin Peptide in Multiple Sclerosis (MS) — COMPLETED
• Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis — COMPLETED · PHASE2

Refine this search